{"title":"Peptides - Calc","description":"","products":[{"product_id":"pt-141-10-mg","title":"PT-141 – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003ePT-141\u003c\/strong\u003e (bremelanotide) is a cyclic melanocortin peptide that acts on the \u003cstrong\u003eMC3R\/MC4R receptors in the central nervous system\u003c\/strong\u003e — a mechanism distinct from PDE5 inhibitors like sildenafil, which act on blood flow. It works upstream, on the brain’s arousal pathway.\u003c\/p\u003e\n\u003cp\u003eIn two randomized \u003cstrong\u003ePhase 3 trials\u003c\/strong\u003e (RECONNECT, 1,267 women), bremelanotide significantly improved \u003cstrong\u003esexual desire\u003c\/strong\u003e and reduced desire-related distress versus placebo (P\u0026lt;0.001)\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1097\/AOG.0000000000003500\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. It is \u003cstrong\u003eFDA-approved (Vyleesi)\u003c\/strong\u003e for premenopausal hypoactive sexual desire disorder.\u003c\/p\u003e\n\u003cp\u003eBecause it targets central melanocortin signaling rather than vasculature, it is studied for arousal that begins in the CNS. Reported effects include transient nausea, flushing and headache.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106770659,"sku":"PT-10","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-pt-141-10-mg.png?v=1784483771"},{"product_id":"aod-9604-5-mg","title":"AOD-9604 – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eAOD-9604\u003c\/strong\u003e is the \u003cstrong\u003eC-terminal lipolytic fragment of human growth hormone\u003c\/strong\u003e (hGH 176–191) — the fat-metabolism domain of the hormone, isolated from the rest of the molecule.\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, chronic AOD-9604 \u003cstrong\u003esignificantly reduced body-weight gain\u003c\/strong\u003e and increased \u003cstrong\u003efat oxidation and lipolysis\u003c\/strong\u003e in obese mice\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/endo.142.12.8522\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/sj.ijo.0801740\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eCritically, and \u003cem\u003eunlike\u003c\/em\u003e full hGH, AOD-9604 \u003cstrong\u003edid not raise blood glucose or suppress insulin\u003c\/strong\u003e, and it does \u003cstrong\u003enot bind the hGH receptor\u003c\/strong\u003e or the IGF-1 pathway\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/sj.ijo.0801740\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e — separating fat metabolism from growth-hormone side effects.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106803427,"sku":"AOD-5","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-aod-9604-5-mg.png?v=1784483779"},{"product_id":"ghk-cu-100-mg","title":"GHK-Cu – 100 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e is the human copper-binding tripeptide (glycyl-L-histidyl-L-lysine + copper) — a natural signal for \u003cstrong\u003eskin remodeling and repair\u003c\/strong\u003e whose levels decline with age.\u003c\/p\u003e\n\u003cp\u003eIn controlled studies on aged skin, GHK-Cu \u003cstrong\u003etightened skin, improved elasticity and firmness, and reduced fine lines, wrinkles and photodamage\u003c\/strong\u003e; mechanistically it boosts collagen and elastin synthesis and fibroblast proliferation\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBeyond skin, GHK-Cu acts as a broad regenerative signal — \u003cstrong\u003eantioxidant and anti-inflammatory\u003c\/strong\u003e — and up- and down-regulates a large set of human genes tied to tissue repair\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2012\/324832\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published cosmetic and preclinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106868963,"sku":"CU100","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/bp_ghkcu100.png?v=1784552355"},{"product_id":"bpc-157-tb-500-blend-5-mg-5-mg","title":"BPC-157 + TB-500 Blend – 5 mg \/ 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003eThis blend pairs \u003cstrong\u003eBPC-157\u003c\/strong\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e (5 mg each) — two of the most-studied repair peptides — chosen for their \u003cstrong\u003ecomplementary mechanisms\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e has shown localized effects on tendon, ligament and gut tissue and strong pro-angiogenic activity in preclinical models\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e (thymosin β4) drives systemic \u003cstrong\u003ecell migration and angiogenesis\u003c\/strong\u003e, accelerating endothelial migration several-fold in preclinical research\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a two-peptide \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106901731,"sku":"BB10","price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-bpc-157-tb-500-5-mg-5-mg_352294ae-ac01-4744-b4a5-3d29b80523d3.png?v=1784485192"},{"product_id":"b12-10-mg","title":"B12 – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eVitamin B12\u003c\/strong\u003e (cyanocobalamin) is a water-soluble \u003cstrong\u003ecofactor\u003c\/strong\u003e at the centre of cellular energy metabolism, the \u003cstrong\u003emethylation cycle\u003c\/strong\u003e, DNA synthesis and red-blood-cell formation — one of the most fundamental molecules in metabolic research\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/nrdp.2017.40\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBiochemically it serves two enzymes: \u003cstrong\u003emethionine synthase\u003c\/strong\u003e, which remethylates \u003cstrong\u003ehomocysteine to methionine\u003c\/strong\u003e and regenerates the cell’s methyl-donor pool, and \u003cstrong\u003emethylmalonyl-CoA mutase\u003c\/strong\u003e in mitochondrial energy metabolism\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/nrdp.2017.40\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMcp1113996\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBecause B12 status governs homocysteine, it features in cognition research: in the randomized, placebo-controlled \u003cstrong\u003eVITACOG\u003c\/strong\u003e trial, homocysteine-lowering B vitamins (including B12) \u003cstrong\u003eslowed the rate of brain atrophy\u003c\/strong\u003e in older adults with mild cognitive impairment — an effect concentrated in those with elevated baseline homocysteine\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0012244\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published biochemical and clinical research on the vitamin B12 molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106934499,"sku":"B12","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-b12-10-mg.png?v=1784483802"},{"product_id":"mots-c-10-mg","title":"MOTS-C – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eMOTS-c\u003c\/strong\u003e is a \u003cstrong\u003e16-amino-acid mitochondrial-derived peptide\u003c\/strong\u003e — encoded inside the mitochondrial genome itself — that acts as a metabolic signal often described as an \u003cstrong\u003e“exercise mimetic.”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, MOTS-c treatment \u003cstrong\u003eprevented high-fat-diet-induced obesity\u003c\/strong\u003e and both \u003cstrong\u003eage- and diet-induced insulin resistance\u003c\/strong\u003e in mice, acting through \u003cstrong\u003eAMPK activation\u003c\/strong\u003e in skeletal muscle\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2015.02.009\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eExercise raises the body’s own MOTS-c in human muscle and blood; in mice, MOTS-c treatment \u003cstrong\u003eenhanced physical performance\u003c\/strong\u003e across young, middle-aged and old animals\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-020-20790-0\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e — which is why it is studied for metabolic health and healthspan research.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal and cell-based) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106967267,"sku":"MS10","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-mots-c-10-mg.png?v=1784483808"},{"product_id":"ipamorelin-10-mg","title":"Ipamorelin – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e is a pentapeptide \u003cstrong\u003eghrelin-receptor (GHS-R) agonist\u003c\/strong\u003e — a growth-hormone-releasing peptide that triggers a clean pulse of GH.\u003c\/p\u003e\n\u003cp\u003eIn the study that introduced it, ipamorelin released GH with a potency matching earlier GHRPs but — uniquely — \u003cstrong\u003ewithout raising cortisol or prolactin\u003c\/strong\u003e, even at 200× the effective dose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1390552\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. That selectivity is its defining feature.\u003c\/p\u003e\n\u003cp\u003eIt pairs naturally with a \u003cstrong\u003eGHRH analog\u003c\/strong\u003e such as CJC-1295: the two act on different receptors to amplify the growth-hormone pulse.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal and cell-based) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107000035,"sku":"IP10","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-ipamorelin-10-mg.png?v=1784483816"},{"product_id":"tesamorelin-10-mg","title":"Tesamorelin – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is a \u003cstrong\u003estabilized GHRH analog\u003c\/strong\u003e and the only GHRH-analog peptide to reach \u003cstrong\u003eFDA approval\u003c\/strong\u003e (as Egrifta) — studied specifically for deep abdominal (visceral) fat.\u003c\/p\u003e\n\u003cp\u003eIn a randomized human trial, daily tesamorelin reduced \u003cstrong\u003evisceral adipose tissue by 18%\u003c\/strong\u003e over 52 weeks and lowered triglycerides, without clinically significant changes in glucose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1097\/QAD.0b013e32830a5058\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt acts on the pituitary \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e to restore GH\/IGF-1 signaling; visceral fat re-accumulates once treatment stops, underlining that the effect is treatment-dependent.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107065571,"sku":"TSM10","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-tesamorelin-10-mg.png?v=1784483823"},{"product_id":"semax-5-mg","title":"Semax – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSemax\u003c\/strong\u003e is a synthetic heptapeptide analog of the \u003cstrong\u003eACTH (4-10)\u003c\/strong\u003e fragment — but with the hormonal (corticotropic) activity removed, leaving a \u003cstrong\u003enon-hormonal neuropeptide\u003c\/strong\u003e studied for cognition and neuroprotection.\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, a single dose of Semax raised hippocampal \u003cstrong\u003eBDNF ~1.4×\u003c\/strong\u003e and tripled BDNF mRNA (with matching increases in its trkB receptor), alongside improved learning in behavioural tests\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBy amplifying the \u003cstrong\u003eBDNF\/trkB neuroplasticity system\u003c\/strong\u003e, it is investigated for memory, focus, stroke recovery and mood research — typically via intranasal delivery.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107098339,"sku":"XA5","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-semax-5-mg.png?v=1784483830"},{"product_id":"selank-5-mg","title":"Selank – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSelank\u003c\/strong\u003e is a synthetic analog of the immune peptide \u003cstrong\u003etuftsin\u003c\/strong\u003e — an anxiolytic neuropeptide studied for calm and cognition without the drawbacks of classical sedatives.\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, Selank produced an \u003cstrong\u003eanxiolytic effect comparable to benzodiazepines\u003c\/strong\u003e (diazepam) in stress models — but \u003cstrong\u003ewithout the sedation or dependence\u003c\/strong\u003e associated with them\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2017\/5091027\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is thought to act by modulating \u003cstrong\u003eGABA and serotonin signaling\u003c\/strong\u003e and BDNF expression, and is investigated for anxiety, focus and memory research.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107131107,"sku":"SK5","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-selank-5-mg.png?v=1784483838"},{"product_id":"grow-h-10mg-cjc-1295-no-dac-ipamorelin","title":"GROW-H – CJC-1295 (No DAC) + Ipamorelin – 5 mg \/ 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGROW-H\u003c\/strong\u003e pairs \u003cstrong\u003eCJC-1295 (No DAC)\u003c\/strong\u003e and \u003cstrong\u003eIpamorelin\u003c\/strong\u003e (5 mg each) — a GHRH analog plus a GHRP — the classic “amplify from two receptors” stack.\u003c\/p\u003e\n\u003cp\u003eIn healthy adults, \u003cstrong\u003eCJC-1295\u003c\/strong\u003e produced sustained increases in GH (\u003cstrong\u003e2- to 10-fold\u003c\/strong\u003e) and IGF-1 (\u003cstrong\u003e1.5- to 3-fold\u003c\/strong\u003e) lasting days per dose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jc.2005-1536\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e adds a selective GH pulse \u003cstrong\u003ewithout the cortisol spike\u003c\/strong\u003e of older secretagogues\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1390552\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e, so the two together drive a larger, cleaner release than either alone.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical (CJC-1295) and preclinical (Ipamorelin) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107196643,"sku":"CP10","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-grow-h-10-mg-blend-v2.png?v=1784487677"},{"product_id":"sermorelin-10mg","title":"Sermorelin – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSermorelin\u003c\/strong\u003e is \u003cstrong\u003eGHRH (1-29)\u003c\/strong\u003e — the shortest fully active fragment of growth-hormone-releasing hormone. It prompts the pituitary to release the body’s \u003cstrong\u003eown growth hormone\u003c\/strong\u003e in natural pulses, rather than supplying synthetic GH.\u003c\/p\u003e\n\u003cp\u003eIn a randomized trial of age-advanced adults, nightly GHRH (1-29) significantly raised \u003cstrong\u003enocturnal GH and IGF-1\u003c\/strong\u003e within two weeks, and increased \u003cstrong\u003elean body mass\u003c\/strong\u003e and skin thickness over 16 weeks\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.82.5.3943\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBecause it works through the natural \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e, growth-hormone output stays under the body’s own feedback control — a key contrast with exogenous GH.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107229411,"sku":"SMO10","price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-sermorelin-10-mg.png?v=1784483869"},{"product_id":"sermorelin-5mg","title":"Sermorelin – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSermorelin\u003c\/strong\u003e is \u003cstrong\u003eGHRH (1-29)\u003c\/strong\u003e — the shortest fully active fragment of growth-hormone-releasing hormone. It prompts the pituitary to release the body’s \u003cstrong\u003eown growth hormone\u003c\/strong\u003e in natural pulses, rather than supplying synthetic GH.\u003c\/p\u003e\n\u003cp\u003eIn a randomized trial of age-advanced adults, nightly GHRH (1-29) significantly raised \u003cstrong\u003enocturnal GH and IGF-1\u003c\/strong\u003e within two weeks, and increased \u003cstrong\u003elean body mass\u003c\/strong\u003e and skin thickness over 16 weeks\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.82.5.3943\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBecause it works through the natural \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e, growth-hormone output stays under the body’s own feedback control — a key contrast with exogenous GH.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107262179,"sku":"Serm-5","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-sermorelin-5-mg.png?v=1784483876"},{"product_id":"klow-80mg","title":"KLOW – 80 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eKLOW\u003c\/strong\u003e combines four peptides — \u003cstrong\u003eKPV, GHK-Cu, BPC-157 and TB-500\u003c\/strong\u003e — spanning inflammation, skin and tissue repair in a single blend.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e (derived from α-MSH) is the anti-inflammatory arm: in murine models it significantly reduced inflammation and sped recovery\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/ibd.20334\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e adds skin remodeling — collagen, elasticity and reduced wrinkles in controlled studies\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e complete the repair layer, accelerating cell migration and angiogenesis in preclinical research\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[4]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical and cosmetic research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107524323,"sku":"KLOW","price":170.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/bp_klow.png?v=1784552346"},{"product_id":"retatrutide-24mg","title":"Retatrutide – 24 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e — a single molecule that activates the \u003cstrong\u003eGIP\u003c\/strong\u003e, \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptors at once. The added glucagon arm is thought to raise \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e on top of the appetite reduction driven by GIP and GLP-1\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a 48-week \u003cstrong\u003ePhase 2 obesity trial\u003c\/strong\u003e, participants on the 12 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 24.2%\u003c\/strong\u003e, versus 2.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e83%\u003c\/strong\u003e of that group lost 15% or more of their body weight, and \u003cstrong\u003e93%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a separate \u003cstrong\u003ePhase 2 type-2-diabetes trial\u003c\/strong\u003e, retatrutide lowered HbA1c by up to \u003cstrong\u003e2.02 points\u003c\/strong\u003e and cut body weight by about \u003cstrong\u003e16.9%\u003c\/strong\u003e at 36 weeks — outperforming the GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the retatrutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107557091,"sku":"RT26-A","price":195.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-retatrutide-24-mg.png?v=1784483919"},{"product_id":"retatrutide-12mg","title":"Retatrutide – 12 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e — a single molecule that activates the \u003cstrong\u003eGIP\u003c\/strong\u003e, \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptors at once. The added glucagon arm is thought to raise \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e on top of the appetite reduction driven by GIP and GLP-1\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a 48-week \u003cstrong\u003ePhase 2 obesity trial\u003c\/strong\u003e, participants on the 12 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 24.2%\u003c\/strong\u003e, versus 2.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e83%\u003c\/strong\u003e of that group lost 15% or more of their body weight, and \u003cstrong\u003e93%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a separate \u003cstrong\u003ePhase 2 type-2-diabetes trial\u003c\/strong\u003e, retatrutide lowered HbA1c by up to \u003cstrong\u003e2.02 points\u003c\/strong\u003e and cut body weight by about \u003cstrong\u003e16.9%\u003c\/strong\u003e at 36 weeks — outperforming the GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the retatrutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107589859,"sku":"RT14-A","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-retatrutide-12-mg.png?v=1784483934"},{"product_id":"retatrutide-6mg","title":"Retatrutide – 6 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e — a single molecule that activates the \u003cstrong\u003eGIP\u003c\/strong\u003e, \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptors at once. The added glucagon arm is thought to raise \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e on top of the appetite reduction driven by GIP and GLP-1\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a 48-week \u003cstrong\u003ePhase 2 obesity trial\u003c\/strong\u003e, participants on the 12 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 24.2%\u003c\/strong\u003e, versus 2.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e83%\u003c\/strong\u003e of that group lost 15% or more of their body weight, and \u003cstrong\u003e93%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a separate \u003cstrong\u003ePhase 2 type-2-diabetes trial\u003c\/strong\u003e, retatrutide lowered HbA1c by up to \u003cstrong\u003e2.02 points\u003c\/strong\u003e and cut body weight by about \u003cstrong\u003e16.9%\u003c\/strong\u003e at 36 weeks — outperforming the GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the retatrutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107622627,"sku":"RT7-A","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-retatrutide-6-mg.png?v=1784483905"},{"product_id":"ghk-cu-50mg","title":"GHK-Cu – 50 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e is the human copper-binding tripeptide (glycyl-L-histidyl-L-lysine + copper) — a natural signal for \u003cstrong\u003eskin remodeling and repair\u003c\/strong\u003e whose levels decline with age.\u003c\/p\u003e\n\u003cp\u003eIn controlled studies on aged skin, GHK-Cu \u003cstrong\u003etightened skin, improved elasticity and firmness, and reduced fine lines, wrinkles and photodamage\u003c\/strong\u003e; mechanistically it boosts collagen and elastin synthesis and fibroblast proliferation\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBeyond skin, GHK-Cu acts as a broad regenerative signal — \u003cstrong\u003eantioxidant and anti-inflammatory\u003c\/strong\u003e — and up- and down-regulates a large set of human genes tied to tissue repair\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2012\/324832\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published cosmetic and preclinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107688163,"sku":"CU50","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/bp_ghkcu50.png?v=1784552364"},{"product_id":"semaglutide-5mg","title":"Semaglutide – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e is the most extensively studied \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e — a single, highly selective incretin-pathway agonist that has become the reference standard against which newer dual and triple agonists are measured. It acts on appetite signaling, glucose-dependent insulin release and gastric emptying.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 68-week \u003cstrong\u003eSTEP 1\u003c\/strong\u003e obesity trial, participants on 2.4 mg recorded a mean \u003cstrong\u003ebody-weight reduction of 14.9%\u003c\/strong\u003e, versus 2.4% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e50%\u003c\/strong\u003e lost 15% or more of their body weight, and \u003cstrong\u003e69%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIts evidence base runs deep: in \u003cstrong\u003etype-2 diabetes\u003c\/strong\u003e (SUSTAIN 1) semaglutide cut HbA1c by \u003cstrong\u003e1.55 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S2213-8587(17)30013-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e, and in the 17,604-patient \u003cstrong\u003eSELECT\u003c\/strong\u003e cardiovascular trial it reduced major cardiac events by \u003cstrong\u003e20%\u003c\/strong\u003e in adults with obesity and no diabetes\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2307563\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the semaglutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107720931,"sku":"SM5","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-glp-1sg-5-mg.png?v=1784483979"},{"product_id":"tb-500-thymosin-beta-4-43-aa-5mg","title":"TB-500 – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e is the full \u003cstrong\u003e43-amino-acid thymosin β4\u003c\/strong\u003e peptide — a naturally occurring actin-regulating protein central to \u003cstrong\u003ecell migration\u003c\/strong\u003e and tissue repair.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003epreclinical research\u003c\/strong\u003e, thymosin β4 acted as a potent chemoattractant, accelerating \u003cstrong\u003eendothelial-cell migration four- to six-fold\u003c\/strong\u003e and promoting angiogenesis\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn rodent models it promoted \u003cstrong\u003eangiogenesis and wound repair\u003c\/strong\u003e in both young and aged animals, alongside effects on hair-follicle development\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.mad.2003.11.005\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816107819235,"sku":"TB5","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-tb-500-5-mg.png?v=1784483987"},{"product_id":"tirzepatide-10mg","title":"Tirzepatide – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816108048611,"sku":"T10","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-tirzepatide-10-mg.png?v=1784483890"},{"product_id":"tirzepatide-5mg","title":"Tirzepatide – 5 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816108474595,"sku":"T05","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-tirzepatide-5-mg.png?v=1784483994"},{"product_id":"semaglutide-10mg","title":"Semaglutide – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e is the most extensively studied \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e — a single, highly selective incretin-pathway agonist that has become the reference standard against which newer dual and triple agonists are measured. It acts on appetite signaling, glucose-dependent insulin release and gastric emptying.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 68-week \u003cstrong\u003eSTEP 1\u003c\/strong\u003e obesity trial, participants on 2.4 mg recorded a mean \u003cstrong\u003ebody-weight reduction of 14.9%\u003c\/strong\u003e, versus 2.4% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e50%\u003c\/strong\u003e lost 15% or more of their body weight, and \u003cstrong\u003e69%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIts evidence base runs deep: in \u003cstrong\u003etype-2 diabetes\u003c\/strong\u003e (SUSTAIN 1) semaglutide cut HbA1c by \u003cstrong\u003e1.55 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S2213-8587(17)30013-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e, and in the 17,604-patient \u003cstrong\u003eSELECT\u003c\/strong\u003e cardiovascular trial it reduced major cardiac events by \u003cstrong\u003e20%\u003c\/strong\u003e in adults with obesity and no diabetes\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2307563\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the semaglutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816108998883,"sku":"SM10","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-glp-1sg-10-mg.png?v=1784484003"},{"product_id":"tirzepatide-30mg","title":"Tirzepatide – 30 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e\n.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}\n.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}\n.qvg-desc-rt strong{color:#233137;font-weight:500}\n.qvg-desc-rt em{color:#8a969b}\n.qvg-desc-rt sup{line-height:0}\n.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}\n.qvg-desc-rt sup a:hover{color:#233137}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816109490403,"sku":"T30","price":170.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-tirzepatide-30-mg.png?v=1784483949"},{"product_id":"melanotan-ii-10mg","title":"Melanotan II – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eMelanotan II\u003c\/strong\u003e is a synthetic, cyclic analog of \u003cstrong\u003eα-MSH\u003c\/strong\u003e (α-melanocyte-stimulating hormone) that activates melanocortin receptors — most notably \u003cstrong\u003eMC1R\u003c\/strong\u003e on skin melanocytes, driving melanin production (pigmentation).\u003c\/p\u003e\n\u003cp\u003eIn a human \u003cstrong\u003ePhase I study\u003c\/strong\u003e, subcutaneous MT-II increased skin pigmentation (measured by quantitative reflectance) after only a few low doses, alongside central melanocortin effects\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/0024-3205(96)00160-9\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eMelanotan II is an \u003cstrong\u003eunlicensed research compound\u003c\/strong\u003e and its long-term safety is not established; it is provided strictly for laboratory research.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical (Phase I) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816109555939,"sku":"ML10","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-melanotan-ii-10-mg.png?v=1784484016"},{"product_id":"cagrilintide-10mg","title":"Cagrilintide – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e is a long-acting analog of \u003cstrong\u003eamylin\u003c\/strong\u003e — a pancreatic satiety hormone — acting on the \u003cstrong\u003eamylin receptor\u003c\/strong\u003e. It works through a satiety pathway that is \u003cstrong\u003edistinct from, and complementary to, GLP-1\u003c\/strong\u003e, which is why it is widely studied both alone and stacked with GLP-1 agonists.\u003c\/p\u003e\n\u003cp\u003eIn a 26-week \u003cstrong\u003ePhase 2\u003c\/strong\u003e obesity trial, cagrilintide 4.5 mg produced a mean \u003cstrong\u003ebody-weight reduction of 10.8%\u003c\/strong\u003e, versus 3.0% on placebo — and it \u003cstrong\u003eoutperformed liraglutide 3.0 mg\u003c\/strong\u003e (10.8% vs 9.0%)\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(21)01751-7\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIts most-studied use is in \u003cstrong\u003ecombination\u003c\/strong\u003e: co-administered with semaglutide (\u003cstrong\u003eCagriSema\u003c\/strong\u003e), weight loss reached \u003cstrong\u003e15.6%\u003c\/strong\u003e at 32 weeks — far beyond semaglutide alone (5.1%)\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01163-7\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the cagrilintide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816109588707,"sku":"CGL10","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-cagrilintide-10-mg.png?v=1784484024"},{"product_id":"bpc-157-10mg","title":"BPC-157 – 10 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e (Body Protection Compound) is a stable pentadecapeptide derived from a protein found in gastric juice, studied for its broad \u003cstrong\u003etissue-repair\u003c\/strong\u003e activity across tendon, ligament, gut and vascular tissue.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003epreclinical research\u003c\/strong\u003e, BPC-157 accelerated the outgrowth and \u003cstrong\u003emigration of tendon fibroblasts\u003c\/strong\u003e and improved their survival under oxidative stress, via the FAK–paxillin pathway\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is also strongly \u003cstrong\u003epro-angiogenic\u003c\/strong\u003e: in rat and endothelial-cell models it promoted new blood-vessel formation and blood-flow recovery by up-regulating the \u003cstrong\u003eVEGFR2–Akt–eNOS\u003c\/strong\u003e pathway\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1007\/s00109-016-1488-y\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816109654243,"sku":"BC10","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-bpc-157-10-mg.png?v=1784484039"},{"product_id":"glow-blend","title":"GLOW – 70 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGLOW\u003c\/strong\u003e pairs three of the most-studied regenerative peptides — \u003cstrong\u003eGHK-Cu, BPC-157 and TB-500\u003c\/strong\u003e — for a skin-and-tissue blend that targets appearance and repair together.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e drives collagen\/elastin synthesis and, in controlled aged-skin studies, improved elasticity and reduced wrinkles\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e add the repair layer: in preclinical research BPC-157 accelerated tendon-cell migration\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e and TB-500 (thymosin β4) drove endothelial migration and angiogenesis\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published cosmetic and preclinical research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816109719779,"sku":"GLOW","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/bp_glow.png?v=1784552337"}],"url":"https:\/\/qovigen.com\/collections\/peptides-calc.oembed","provider":"Qovigen Peptides","version":"1.0","type":"link"}